AU523095B2 - Simethicone antacid tablet - Google Patents

Simethicone antacid tablet

Info

Publication number
AU523095B2
AU523095B2 AU51057/79A AU5105779A AU523095B2 AU 523095 B2 AU523095 B2 AU 523095B2 AU 51057/79 A AU51057/79 A AU 51057/79A AU 5105779 A AU5105779 A AU 5105779A AU 523095 B2 AU523095 B2 AU 523095B2
Authority
AU
Australia
Prior art keywords
simethicone
antacid tablet
antacid
tablet
simethicone antacid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU51057/79A
Other languages
English (en)
Other versions
AU5105779A (en
Inventor
Joseph Alfred Rider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rider J A
Original Assignee
Rider J A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rider J A filed Critical Rider J A
Publication of AU5105779A publication Critical patent/AU5105779A/en
Application granted granted Critical
Publication of AU523095B2 publication Critical patent/AU523095B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU51057/79A 1979-01-31 1979-09-21 Simethicone antacid tablet Ceased AU523095B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US007887 1979-01-31
US06/007,887 US4198390A (en) 1979-01-31 1979-01-31 Simethicone antacid tablet

Publications (2)

Publication Number Publication Date
AU5105779A AU5105779A (en) 1980-08-07
AU523095B2 true AU523095B2 (en) 1982-07-08

Family

ID=21728641

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51057/79A Ceased AU523095B2 (en) 1979-01-31 1979-09-21 Simethicone antacid tablet

Country Status (6)

Country Link
US (1) US4198390A (https=)
EP (1) EP0014253B1 (https=)
JP (1) JPS55102513A (https=)
AU (1) AU523095B2 (https=)
CA (1) CA1139662A (https=)
DE (1) DE2967263D1 (https=)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4396604A (en) * 1982-05-17 1983-08-02 Norcliff Thayer, Inc. Simethicone antacid lozenge
US4518433A (en) * 1982-11-08 1985-05-21 Fmc Corporation Enteric coating for pharmaceutical dosage forms
GB8830407D0 (en) * 1988-12-30 1989-03-01 Embil Koral Pharmaceutical formulations
US6482516B1 (en) * 1993-07-20 2002-11-19 Banner Pharmacaps, Inc. Enrobed tablet
DE69116989D1 (de) * 1990-06-28 1996-03-21 Edko Trading Representation Mehrphasige pharmazeutische Zusammensetzungen
US5272137A (en) * 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
GR1002332B (el) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
CA2110313C (en) * 1992-12-01 2004-10-26 Edward John Roche Pharmaceutical compositions containing a guanidinothiazole compound and antacids
CA2150463A1 (en) * 1992-12-02 1994-06-09 Donald F. H. Wallach Extended duration antacid product
WO1996004128A1 (de) * 1994-08-03 1996-02-15 Voss Gunter M Verfahren zur herstellung von manteltabletten
JP3001440B2 (ja) * 1996-11-25 2000-01-24 日本電気通信システム株式会社 仮想ｌａｎ方式
US5846567A (en) * 1997-04-16 1998-12-08 Chek-Med Systems, Inc. Clot dissolving method
EP1057472B1 (en) * 1997-12-03 2006-07-26 Kao Corporation Solid preparation for oral hygiene
FR2774906B1 (fr) * 1998-02-13 2000-05-12 Rhodia Chimie Sa Systeme d'encapsulation a coeur organique et a ecorce minerale a base d'hydroxycarbonate d'aluminium et son procede de preparation
US6399591B1 (en) * 2000-01-19 2002-06-04 Yung-Shin Pharmaceutical Ind. Co., Ltd. Chargeable pharmaceutical tablets
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
CA2461616A1 (en) * 2001-09-28 2003-04-03 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US7807197B2 (en) * 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US20110027356A1 (en) * 2008-01-25 2011-02-03 Duo-Ge Combination of Oral Medicaments Bonded by a Wrapping
BRPI0918492A2 (pt) 2008-09-09 2015-12-01 Astrazeneca Ab uso de naproxen, ou sal farmaceuticamente aceitável do mesmo, e esomeprazol, ou sal farmaceuticamente aceitável do mesmo
AU2010266026B2 (en) * 2009-06-25 2014-08-07 Nuvo Pharmaceuticals (Ireland) Designated Activity Company Method for treating a patient in need of aspirin therapy
EP2445499A4 (en) 2009-06-25 2013-02-27 Astrazeneca Ab METHOD FOR TREATING A PATIENT WITH RISK OF DEVELOPING A NSAID-ASSOCIATED SPURGE
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
UA115139C2 (uk) 2011-12-28 2017-09-25 Поузен Інк. Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form
CN104363897A (zh) 2012-06-12 2015-02-18 宝洁公司 泡腾剂型
EP3294269A1 (en) 2015-06-12 2018-03-21 Santa Farma Ilaç Sanayi A.S. Oral pharmaceutical composition comprising otilonium bromide and simethicone with certain bulk density and improved dissolution characteristics
KR20230137362A (ko) 2016-05-05 2023-10-04 어퀘스티브 테라퓨틱스, 아이엔씨. 강화된 전달 에프네프린 조성물
US12427121B2 (en) 2016-05-05 2025-09-30 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
US12433850B2 (en) 2016-05-05 2025-10-07 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine and prodrug compositions
EP4422607A4 (en) 2021-10-25 2025-09-03 Aquestive Therapeutics Inc ORAL AND NASAL COMPOSITIONS AND METHODS OF TREATMENT
CN116139165B (zh) * 2023-02-13 2024-10-01 南京艾德加生物制药科技有限公司 铝镁西甲硅油咀嚼片及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US462990A (en) * 1891-11-10 William oppenheimek
US2512192A (en) * 1948-05-26 1950-06-20 American Cyanamid Co Silicone resin medicament coating
US3048526A (en) * 1958-08-04 1962-08-07 Wander Company Medicinal tablet
US3422189A (en) * 1959-01-02 1969-01-14 Moraine Products Method and compositions for the treatment of gastro-intestinal disorders
US3096248A (en) * 1959-04-06 1963-07-02 Rexall Drug & Chemical Company Method of making an encapsulated tablet
GB971486A (en) * 1960-04-01 1964-09-30 Rech S Pharma Et Scient Therapeutic compositions comprising aspirin and polysiloxanes
USRE25205E (en) 1960-10-10 1962-07-24 Silicone composition for the relief of
AU407324B2 (en) * 1962-05-01 1970-10-28 Smith, Kline & French Laboratories Powdered silicone products and processes
US3501571A (en) * 1965-12-06 1970-03-17 Smithkline Corp Novel silicone compositions and method of preparing same
US3567819A (en) * 1969-01-30 1971-03-02 Hoffmann La Roche Cold tablet
US3767794A (en) * 1969-11-21 1973-10-23 Richardson Merrell Inc Antifoam preparations and method of preparing same
FR2077913A1 (en) * 1970-02-24 1971-11-05 Sogeras Tablets contg gelatine capsules - for administration of liquid medicaments
US4127650A (en) * 1975-03-31 1978-11-28 William H. Rorer, Inc. Medicinal simethicone containing composition and its method of production
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations

Also Published As

Publication number Publication date
JPS643845B2 (https=) 1989-01-23
US4198390A (en) 1980-04-15
AU5105779A (en) 1980-08-07
JPS55102513A (en) 1980-08-05
CA1139662A (en) 1983-01-18
EP0014253B1 (en) 1984-10-17
EP0014253A3 (en) 1981-01-28
DE2967263D1 (en) 1984-11-22
EP0014253A2 (en) 1980-08-20

Similar Documents

Publication Publication Date Title
AU523095B2 (en) Simethicone antacid tablet
AU534332B2 (en) Capsule orientation
AU515341B2 (en) Pharmaceutical composition
AU529317B2 (en) Antacid composition
AU532626B2 (en) Monacolink
AU574695B2 (en) B-41 milbemycim compounds
AU523794B2 (en) Pharmaceutical tablet
AU533347B2 (en) Can top
AU525122B2 (en) Antacid tablet formulation
AU525431B2 (en) Emulsans
AU8436082A (en) Apap antacid composition
AU533637B2 (en) Polyethers
AU531808B2 (en) Tetrahydrobenzothiazolylimidazolidinones
AU508191B2 (en) Pharmaceutical composition
AU4841379A (en) Z-aza-ergolines
AU5831480A (en) N-oximinoalkyl-anilides
AU534771B2 (en) Analgesic
AU526324B2 (en) Buildibg structure
AU5578380A (en) N1-vinyl-n1-methyl-n2-aryl-formamidines
AU532764B2 (en) Double layer tablet
AU3302184A (en) Woolpack
AU4319879A (en) Boat-carrier
AU544072B2 (en) Corner connection
AU523848B2 (en) Spacer-damper
AU523015B2 (en) N-substituted-6-oxamorphinans